{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:14:42Z","timestamp":1786497282120,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T00:00:00Z","timestamp":1662163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bladder cancer (BC) is one of the most common malignancies of the genitourinary system. Animal models offer an important tool to explore tumour initiation, progression, and therapeutic mechanisms. Our aim is to construct an optimized orthotopic BC model which is predictable, reproducible, and convenient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The optimized orthotopic BC model was constructed in male C57BL\/6 mice utilizing microsyringes to inoculate them with a murine BC cell line (MB49). Anesthetised mice were inoculated with an MB49 cell suspension (10\u00a0\u00b5L) at approximately 5\u2009\u00d7\u200910<jats:sup>6<\/jats:sup>\/mL. The whole process of modelling was observed and monitored every 3\u00a0days for 21\u00a0days utilizing HE staining and transabdominal ultrasonography (TUS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this study, the model showed excellent success rates for tumour formation (96.67%) and metastatic rate (89.66%). Compared to the control group (sham operation), mice in the modelling group had serous cachexia, visible haematuresis and weight loss (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). The lungs, liver, ureter and kidneys were found to have tumour metastasis. Moreover, the average survival time (19.73\u2009\u00b1\u20091.69 d) of modelling mice was significantly shorter than that of the control mice (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), which remained alive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study established a method using microsyringes to inject murine BC cells into the bladder wall, creating a stable transplantable BC model in mice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-022-01093-6","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T19:33:33Z","timestamp":1662233613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Establishment of an optimized orthotopic bladder cancer model in mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinming","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,3]]},"reference":[{"issue":"3","key":"1093_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6 Suppl 1","key":"1093_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","volume":"66","author":"Z Kirkali","year":"2005","unstructured":"Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6 Suppl 1):4\u201334.","journal-title":"Urology"},{"issue":"4","key":"1093_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.euf.2019.09.003","volume":"6","author":"N Lobo","year":"2020","unstructured":"Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, et al. What is the significance of variant histology in urothelial carcinoma? Eur Urol Focus. 2020;6(4):653\u201363.","journal-title":"Eur Urol Focus"},{"issue":"19","key":"1093_CR4","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980\u201391.","journal-title":"JAMA"},{"issue":"3","key":"1093_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM, Cowan NC, De Santis M, Bruins HM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462\u201375.","journal-title":"Eur Urol"},{"issue":"3","key":"1093_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.eururo.2016.10.008","volume":"71","author":"GW Dy","year":"2017","unstructured":"Dy GW, Gore JL, Forouzanfar MH, Naghavi M, Fitzmaurice C. Global burden of urologic cancers, 1990\u20132013. Eur Urol. 2017;71(3):437\u201346.","journal-title":"Eur Urol"},{"issue":"Suppl 3","key":"1093_CR7","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1086\/314065","volume":"31","author":"TL Ratliff","year":"2000","unstructured":"Ratliff TL. Role of animal models in understanding intravesical therapy with bacille Calmette-Gu\u00e9rin. Clin Infect Dis. 2000;31(Suppl 3):S106\u20138.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1093_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/sj.bjc.6690741","volume":"81","author":"Z Xiao","year":"1999","unstructured":"Xiao Z, McCallum TJ, Brown KM, Miller GG, Halls SB, Parney I, et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer. 1999;81(4):638\u201346.","journal-title":"Br J Cancer"},{"issue":"4","key":"1093_CR9","first-page":"1017","volume":"62","author":"IC Summerhayes","year":"1979","unstructured":"Summerhayes IC, Franks LM. Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J Natl Cancer Inst. 1979;62(4):1017\u201323.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"1093_CR10","doi-asserted-by":"publisher","first-page":"e82288","DOI":"10.1371\/journal.pone.0082288","volume":"8","author":"Z Chen","year":"2013","unstructured":"Chen Z, Tao Z-Z, Chen S-M, Chen C, Li F, Xiao B-K. Indole-3-carbinol inhibits nasopharyngeal carcinoma growth through cell cycle arrest in vivo and in vitro. PLoS ONE. 2013;8(12):e82288.","journal-title":"PLoS ONE"},{"issue":"9","key":"1093_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/j.1464-410X.2009.08577.x","volume":"104","author":"E Chan","year":"2009","unstructured":"Chan E, Patel A, Heston W, Larchian W. Mouse orthotopic models for bladder cancer research. BJU Int. 2009;104(9):1286\u201391.","journal-title":"BJU Int"},{"issue":"2","key":"1093_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1590\/S1677-55382008000200013","volume":"34","author":"DC Chade","year":"2008","unstructured":"Chade DC, Andrade PM, Borra RC, Leite KR, Andrade E, Villanova FE, et al. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. Int Braz J Urol. 2008;34(2):220\u20139.","journal-title":"Int Braz J Urol"},{"issue":"2","key":"1093_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.juro.2009.03.076","volume":"182","author":"C Lodillinsky","year":"2009","unstructured":"Lodillinsky C, Rodriguez V, Vauthay L, Sandes E, Casab\u00e9 A, Eij\u00e1n AM. Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer. J Urol. 2009;182(2):749\u201355.","journal-title":"J Urol"},{"issue":"2","key":"1093_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.juro.2011.10.022","volume":"187","author":"LO Reis","year":"2012","unstructured":"Reis LO, Ferreira U, Billis A, Cagnon VHA, F\u00e1varo WJ. Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Gu\u00e9rin immunotherapy for nonmuscle invasive bladder cancer. J Urol. 2012;187(2):438\u201345.","journal-title":"J Urol"},{"issue":"6","key":"1093_CR15","first-page":"2065","volume":"31","author":"J Miyazaki","year":"2011","unstructured":"Miyazaki J, Nishiyama H, Yano I, Nakaya A, Kohama H, Kawai K, et al. The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma. Anticancer Res. 2011;31(6):2065\u201371.","journal-title":"Anticancer Res"},{"issue":"5","key":"1093_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00345-007-0198-z","volume":"25","author":"Z-J Shen","year":"2007","unstructured":"Shen Z-J, Wang Y, Ding G-Q, Pan C-W, Zheng R-M. Study on enhancement of fibronectin-mediated bacillus Calmette-Gu\u00e9rin attachment to urinary bladder wall in rabbits. World J Urol. 2007;25(5):525\u20139.","journal-title":"World J Urol"},{"issue":"3\u20134","key":"1093_CR17","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10555-007-9084-9","volume":"26","author":"PC Black","year":"2007","unstructured":"Black PC, Dinney CPN. Bladder cancer angiogenesis and metastasis\u2013translation from murine model to clinical trial. Cancer Metastasis Rev. 2007;26(3\u20134):623\u201334.","journal-title":"Cancer Metastasis Rev"},{"key":"1093_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF00524156","volume":"66","author":"H Druckrey","year":"1964","unstructured":"Druckrey H, Preussmann R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW. Selective induction of bladder cancer in rats by dibutyl- and N-butyl-N-butanol(4)-nitrosamine. Z Krebsforsch. 1964;66:280\u201390.","journal-title":"Z Krebsforsch"},{"issue":"1","key":"1093_CR19","first-page":"81","volume":"67","author":"S Fukushima","year":"1976","unstructured":"Fukushima S, Hirose M, Tsuda H, Shirai T, Hirao K. Histological classification of urinary bladder cancers in rats induced by N-butyl-n-(4-hydroxybutyl)nitrosamine. Gan. 1976;67(1):81\u201390.","journal-title":"Gan"},{"issue":"8","key":"1093_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1593\/neo.08432","volume":"10","author":"PD Williams","year":"2008","unstructured":"Williams PD, Lee JK, Theodorescu D. Molecular credentialing of rodent bladder carcinogenesis models. Neoplasia (New York, NY). 2008;10(8):838\u201346.","journal-title":"Neoplasia (New York, NY)"},{"issue":"3","key":"1093_CR21","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1073\/pnas.92.3.679","volume":"92","author":"JH Lin","year":"1995","unstructured":"Lin JH, Zhao H, Sun TT. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc Natl Acad Sci USA. 1995;92(3):679\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1093_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1940-6207.CAPR-09-0169","volume":"2","author":"CM Seager","year":"2009","unstructured":"Seager CM, Puzio-Kuter AM, Patel T, Jain S, Cordon-Cardo C, Mc Kiernan J, et al. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer. Cancer Prev Res (Phila). 2009;2(12):1008\u201314.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"1093_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074809","volume":"8","author":"X Yang","year":"2013","unstructured":"Yang X, La Rosa FG, Genova EE, Huber K, Schaack J, Degregori J, et al. Simultaneous activation of Kras and inactivation of p53 induces soft tissue sarcoma and bladder urothelial hyperplasia. PLoS ONE. 2013;8(9): e74809.","journal-title":"PLoS ONE"},{"issue":"1","key":"1093_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrc3858","volume":"15","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi T, Owczarek TB, McKiernan JM, Abate-Shen C. Modelling bladder cancer in mice: opportunities and challenges. Nat Rev Cancer. 2015;15(1):42\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1093_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.juro.2011.10.126","volume":"187","author":"X Zhang","year":"2012","unstructured":"Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, et al. A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer. J Urol. 2012;187(3):1071\u20139.","journal-title":"J Urol"},{"issue":"4","key":"1093_CR26","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/S0022-5347(01)66923-4","volume":"154","author":"CP Dinney","year":"1995","unstructured":"Dinney CP, Fishbeck R, Singh RK, Eve B, Pathak S, Brown N, et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol. 1995;154(4):1532\u20138.","journal-title":"J Urol"},{"issue":"8 Pt 2","key":"1093_CR27","first-page":"2918","volume":"37","author":"MS Soloway","year":"1977","unstructured":"Soloway MS. Intravesical and systemic chemotherapy of murine bladder cancer. Can Res. 1977;37(8 Pt 2):2918\u201329.","journal-title":"Can Res"},{"issue":"6","key":"1093_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0022-5347(17)38618-4","volume":"145","author":"J Chin","year":"1991","unstructured":"Chin J, Kadhim S, Garcia B, Kim YS, Karlik S. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J Urol. 1991;145(6):1297\u2013301.","journal-title":"J Urol"},{"issue":"5","key":"1093_CR29","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0022-5347(01)66827-7","volume":"154","author":"GS Oshinsky","year":"1995","unstructured":"Oshinsky GS, Chen Y, Jarrett T, Anderson AE, Weiss GH. A model of bladder tumor xenografts in the nude rat. J Urol. 1995;154(5):1925\u20139.","journal-title":"J Urol"},{"key":"1093_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1756-9966-27-78","volume":"27","author":"DC Chade","year":"2008","unstructured":"Chade DC, Borra RC, Nascimento IP, Villanova FE, Leite LCC, Andrade E, et al. Immunomodulatory effects of recombinant BCG expressing pertussis toxin on TNF-alpha and IL-10 in a bladder cancer model. J Exp Clin Cancer Res. 2008;27:78.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"1093_CR31","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1016\/j.juro.2009.08.020","volume":"182","author":"ESY Chan","year":"2009","unstructured":"Chan ESY, Patel AR, Smith AK, Klein JB, Thomas AA, Heston WD, et al. Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. J Urol. 2009;182(6):2926\u201331.","journal-title":"J Urol"},{"issue":"3","key":"1093_CR32","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/ijc.10595","volume":"102","author":"J-F Bisson","year":"2002","unstructured":"Bisson J-F, Parache RM, Droulle P, Notter D, Vigneron C, Guillemin F. A new method of implanting orthotopic rat bladder tumor for experimental therapies. Int J Cancer. 2002;102(3):280\u20135.","journal-title":"Int J Cancer"},{"issue":"3","key":"1093_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00941979","volume":"25","author":"F Jiang","year":"1997","unstructured":"Jiang F, Zhou XM. A model of orthotopic murine bladder (MBT-2) tumor implants. Urol Res. 1997;25(3):179\u201382.","journal-title":"Urol Res"},{"issue":"5","key":"1093_CR34","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0022-5347(17)37583-3","volume":"147","author":"R Bachor","year":"1992","unstructured":"Bachor R, Flotte TJ, Scholz M, Dretler S, Hasan T. Comparison of intravenous and intravesical administration of chloro-aluminum sulfonated phthalocyanine for photodynamic treatment in a rat bladder cancer model. J Urol. 1992;147(5):1404\u201310.","journal-title":"J Urol"},{"issue":"2","key":"1093_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0022-5347(17)38314-3","volume":"145","author":"JV Harney","year":"1991","unstructured":"Harney JV, Wahl RL, Liebert M, Kuhl DE, Hutchins GD, Wedemeyer G, et al. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. J Urol. 1991;145(2):279\u201383.","journal-title":"J Urol"},{"issue":"2","key":"1093_CR36","first-page":"617","volume":"43","author":"EH Ibrahiem","year":"1983","unstructured":"Ibrahiem EH, Nigam VN, Brailovsky CA, Madarnas P, Elhilali M. Orthotopic implantation of primary N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer in bladder submucosa: an animal model for bladder cancer study. Can Res. 1983;43(2):617\u201322.","journal-title":"Can Res"},{"key":"1093_CR37","first-page":"375","volume":"49","author":"WW Bonney","year":"1978","unstructured":"Bonney WW, Henstorf JE, Emaus SP, Lubaroff DM, Feldbush TL. Immunostimulation by cryosurgery: an orthotopic model of prostate and bladder cancer in the rat. Natl Cancer Inst Monogr. 1978;49:375\u201381.","journal-title":"Natl Cancer Inst Monogr"},{"issue":"1","key":"1093_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clgc.2020.07.011","volume":"19","author":"M Deuker","year":"2021","unstructured":"Deuker M, Martin T, Stolzenbach F, Rosiello G, Coll\u00e0 Ruvolo C, Nocera L, Tian Z, Becker A, Kluth L, Roos FC, et al. Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities. Clin Genitourin Cancer. 2021;19(1):60\u20138.","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"1093_CR39","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.3390\/ijms22126328","volume":"22","author":"A Erman","year":"2021","unstructured":"Erman A, Kamen\u0161ek U, Dragin Jerman U, Pavlin M, \u010cema\u017ear M, Verani\u010d P, et al. How cancer cells invade bladder epithelium and form tumors: the mouse bladder tumor model as a model of tumor recurrence in patients. Int J Mol Sci. 2021;22(12):6328.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1093_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s40425-019-0620-2","volume":"7","author":"YM Morillon","year":"2019","unstructured":"Morillon YM, Su Z, Schlom J, Greiner JW. Temporal changes within the (bladder) tumor microenvironment that accompany the therapeutic effects of the immunocytokine NHS-IL12. J Immunother Cancer. 2019;7(1):150.","journal-title":"J Immunother Cancer"},{"issue":"8","key":"1093_CR41","first-page":"2523","volume":"10","author":"T Goto","year":"2020","unstructured":"Goto T, Kashiwagi E, Jiang G, Nagata Y, Teramoto Y, Baras AS, et al. Estrogen receptor-\u03b2 signaling induces cisplatin resistance in bladder cancer. Am J Cancer Res. 2020;10(8):2523\u201334.","journal-title":"Am J Cancer Res"},{"key":"1093_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.684140","volume":"12","author":"C Bernardo","year":"2021","unstructured":"Bernardo C, Monteiro FL, Direito I, Amado F, Afreixo V, Santos LL, et al. Association between estrogen receptors and GATA3 in bladder cancer: a systematic review and meta-analysis of their clinicopathological significance. Front Endocrinol (Lausanne). 2021;12: 684140.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1093_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"J Dobruch","year":"2016","unstructured":"Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300\u201310.","journal-title":"Eur Urol"},{"issue":"12","key":"1093_CR44","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.3390\/ijms21124488","volume":"21","author":"K Bilski","year":"2020","unstructured":"Bilski K, Dobruch J, Kozikowski M, Skrzypczyk MA, Oszczud\u0142owski M, Ostrowski J. Urobiome in gender-related diversities of bladder cancer. Int J Mol Sci. 2020;21(12):4488.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1093_CR45","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/biom11040594","volume":"11","author":"E Mart\u00ednez-Rojo","year":"2021","unstructured":"Mart\u00ednez-Rojo E, Berumen LC, Garc\u00eda-Alcocer G, Escobar-Cabrera J. The role of androgens and androgen receptor in human bladder cancer. Biomolecules. 2021;11(4):594.","journal-title":"Biomolecules"},{"issue":"11","key":"1093_CR46","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-20-3095","volume":"81","author":"JL Sottnik","year":"2021","unstructured":"Sottnik JL, Vanderlinden L, Joshi M, Chauca-Diaz A, Owens C, Hansel DE, et al. Androgen receptor regulates CD44 expression in bladder cancer. Can Res. 2021;81(11):2833\u201346.","journal-title":"Can Res"},{"issue":"7","key":"1093_CR47","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1111\/cas.14920","volume":"112","author":"S Wang","year":"2021","unstructured":"Wang S, Cai J, Zhang S, Dong M, Zhang L, Xu Y, et al. Loss of polarity protein Par3, via transcription factor snail, promotes bladder cancer metastasis. Cancer Sci. 2021;112(7):2625\u201341.","journal-title":"Cancer Sci"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-01093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-022-01093-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-01093-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T19:33:50Z","timestamp":1662233630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-022-01093-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1093"],"URL":"https:\/\/doi.org\/10.1186\/s12894-022-01093-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,3]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. This study was performed in line with the principles of the Declaration of Helsinki (as revised in 2013). Approval was granted by the Ethics Committee of Fudan University (NO. SYXK 2020-0032). This study is in accordance with ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declared that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}